We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BSX market cap is 132.44B. The company's latest EPS is USD 1.0653 and P/E is 84.42.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.64B | 3.73B | 3.86B | 4.12B | 4.21B |
Operating Income | 705M | 599M | 690M | 522M | 712M |
Net Income | 504M | 505M | 495M | 324M | 469M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.74B | 9.91B | 11.89B | 12.68B | 14.35B |
Operating Income | 1.48B | -179M | 984M | 1.7B | 2.4B |
Net Income | 4.7B | -115M | 985M | 642M | 1.57B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 34.04B | 35.14B | 36.67B | 37.11B | 38.08B |
Total Liabilities | 14.91B | 15.61B | 16.5B | 16.5B | 17.12B |
Total Equity | 19.13B | 19.53B | 20.17B | 20.61B | 20.96B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 30.57B | 30.78B | 32.23B | 32.47B | 35.14B |
Total Liabilities | 16.69B | 15.45B | 15.61B | 14.9B | 15.61B |
Total Equity | 13.88B | 15.33B | 16.62B | 17.57B | 19.53B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.55B | 2.5B | 164M | 977M | 1.98B |
Investing | -1.52B | -2.57B | -285M | -556M | -1.98B |
Financing | -10M | 5M | 1.57B | 1.59B | 1.6B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.84B | 1.51B | 1.87B | 1.53B | 2.5B |
Investing | -5.04B | -411M | -1.6B | -2.01B | -2.57B |
Financing | 2.97B | 293M | -95M | -548M | 5M |
Market Cap | 132.44B |
Price to Earnings Ratio | 84.42 |
Price to Sales Ratio | 9.24 |
Price to Cash Ratio | 153.23 |
Price to Book Ratio | 6.79 |
Dividend Yield | - |
Shares Outstanding | 1.47B |
Average Volume (1 week) | 2.87M |
Average Volume (1 Month) | 4.54M |
52 Week Change | 55.82% |
52 Week High | 91.93 |
52 Week Low | 57.11 |
Spread (Intraday) | 0.02 (0.02%) |
Company Name | Boston Scientific Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.bostonscientific.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions